These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 37520979)
1. Assessment of prognostic role of a novel 7-lncRNA signature in HCC patients. Qu J; Tao D; Huang W; Lu L; Fan J; Zhang S; Huang F Heliyon; 2023 Aug; 9(8):e18493. PubMed ID: 37520979 [TBL] [Abstract][Full Text] [Related]
2. Construction and Validation of a Ferroptosis-Related lncRNA Signature as a Novel Biomarker for Prognosis, Immunotherapy and Targeted Therapy in Hepatocellular Carcinoma. Zhang Z; Zhang W; Wang Y; Wan T; Hu B; Li C; Ge X; Lu S Front Cell Dev Biol; 2022; 10():792676. PubMed ID: 35295858 [TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma. Fu Y; Wei X; Han Q; Le J; Ma Y; Lin X; Xu Y; Liu N; Wang X; Kong X; Gu J; Tong Y; Wu H BMC Cancer; 2021 Oct; 21(1):1165. PubMed ID: 34717566 [TBL] [Abstract][Full Text] [Related]
4. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma. Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911 [TBL] [Abstract][Full Text] [Related]
5. A prognostic signature based on the expression profile of the ferroptosis-related long non-coding RNAs in hepatocellular carcinoma. Lin X; Yang S Adv Clin Exp Med; 2022 Oct; 31(10):1099-1109. PubMed ID: 35581934 [TBL] [Abstract][Full Text] [Related]
6. Identification of Prognostic Glycolysis-Related lncRNA Signature in Tumor Immune Microenvironment of Hepatocellular Carcinoma. Bai Y; Lin H; Chen J; Wu Y; Yu S Front Mol Biosci; 2021; 8():645084. PubMed ID: 33968985 [No Abstract] [Full Text] [Related]
7. Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma. Xu Z; Peng B; Liang Q; Chen X; Cai Y; Zeng S; Gao K; Wang X; Yi Q; Gong Z; Yan Y Front Immunol; 2021; 12():719175. PubMed ID: 34603293 [TBL] [Abstract][Full Text] [Related]
8. Identification of metabolism-related long non-coding RNA (lncRNA) signature predicts prognosis and immune infiltrates in hepatocellular carcinoma. Wang X; Qian J; Yao N; Pocha C; Kang KJ; Angelico R; Zhu G Ann Transl Med; 2022 May; 10(10):595. PubMed ID: 35722420 [TBL] [Abstract][Full Text] [Related]
9. Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma. Li W; Chen QF; Huang T; Wu P; Shen L; Huang ZL Front Oncol; 2020; 10():780. PubMed ID: 32587825 [No Abstract] [Full Text] [Related]
10. Construction of an Immune-Related Six-lncRNA Signature to Predict the Outcomes, Immune Cell Infiltration, and Immunotherapy Response in Patients With Hepatocellular Carcinoma. Zhou P; Lu Y; Zhang Y; Wang L Front Oncol; 2021; 11():661758. PubMed ID: 34277410 [TBL] [Abstract][Full Text] [Related]
11. Identification of a DNA damage repair-related LncRNA signature for predicting the prognosis and immunotherapy response of hepatocellular carcinoma. Huang F; Zhang C; Yang W; Zhou Y; Yang Y; Yang X; Guo W; Wang B BMC Genomics; 2024 Feb; 25(1):155. PubMed ID: 38326754 [TBL] [Abstract][Full Text] [Related]
12. Analysis of m Wu X; Wang S; Wu X; Chen Q; Cheng J; Qi Z J Cancer; 2024; 15(7):2045-2065. PubMed ID: 38434979 [No Abstract] [Full Text] [Related]
13. Identification of senescence-associated long non-coding RNAs to predict prognosis and immune microenvironment in patients with hepatocellular carcinoma. Gao C; Zhou G; Cheng M; Feng L; Cao P; Zhou G Front Genet; 2022; 13():956094. PubMed ID: 36330438 [No Abstract] [Full Text] [Related]
14. Identification and validation of a five-necroptosis-related lncRNAs signature for prognostic prediction in hepatocellular carcinoma. Chen H; Hou G; Lan T; Xue S; Xu L; Feng Q; Zeng Y; Wang H Heliyon; 2024 Sep; 10(18):e37403. PubMed ID: 39309864 [TBL] [Abstract][Full Text] [Related]
15. A Novel lncRNA Panel Related to Ferroptosis, Tumor Progression, and Microenvironment is a Robust Prognostic Indicator for Glioma Patients. He Y; Ye Y; Tian W; Qiu H Front Cell Dev Biol; 2021; 9():788451. PubMed ID: 34950662 [No Abstract] [Full Text] [Related]
16. Identification of a cuproptosis and copper metabolism gene-related lncRNAs prognostic signature associated with clinical and immunological characteristics of hepatocellular carcinoma. Yuan W; Xiao JH; Zhang JS; Mao BL; Wang PZ; Wang BL Front Oncol; 2023; 13():1153353. PubMed ID: 37056336 [TBL] [Abstract][Full Text] [Related]
17. The development and validation of a novel senescence-related long-chain non-coding RNA (lncRNA) signature that predicts prognosis and the tumor microenvironment of patients with hepatocellular carcinoma. Huang E; Ma T; Zhou J; Ma N; Yang W; Liu C; Hou Z; Chen S; de Castria TB; Zeng B; Zong Z; Zhou T Ann Transl Med; 2022 Jul; 10(14):766. PubMed ID: 35965795 [TBL] [Abstract][Full Text] [Related]
18. Prognostic Signature Constructed of Seven Ferroptosis-Related lncRNAs Predicts the Prognosis of HBV-Related HCC. Wang W; Wang L; Song C; Mu T; Hu J; Feng H J Gastrointest Cancer; 2024 Mar; 55(1):444-456. PubMed ID: 38006465 [TBL] [Abstract][Full Text] [Related]
19. Prognostic effect of a novel long noncoding RNA signature and comparison with clinical staging systems for patients with hepatitis B virus-related hepatocellular carcinoma after hepatectomy. Wu H; Liu TT; Feng YM; Xie XY; Su XN; Qi JN; Zhu Q; Qin CY J Dig Dis; 2020 Nov; 21(11):650-663. PubMed ID: 32959529 [TBL] [Abstract][Full Text] [Related]
20. Identification of a Novel N7-Methylguanosine-Related LncRNA Signature Predicts the Prognosis of Hepatocellular Carcinoma and Experiment Verification. Yang C; Zhang L; Hao X; Tang M; Zhou B; Hou J Curr Oncol; 2022 Dec; 30(1):430-448. PubMed ID: 36661684 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]